Jose Carmona

Jose “Pepe” Carmona joined ADC Therapeutics as Chief Financial Officer in December 2022 bringing over 20 years of financial experience in the biotechnology and pharmaceutical industries.

Prior to ADC Therapeutics, Mr. Carmona was the CFO at Rubius Therapeutics, a biopharmaceutical company engineering red blood cells to create a new class of cellular medicines for cancer and autoimmune diseases. Before joining Rubius Therapeutics, he was the CFO of Radius Health, a global commercial company specializing in bone health. Prior to Radius Health, he served as CFO of Innocoll Holdings PLC, acquired by Gurnet Point L.P. Previously, Mr. Carmona spent 12 years at Novartis AG in numerous global and regional financial management positions across the business, including serving as CFO for divisions in Europe, North America and Latin America. He serves on the board of directors at Senda Biosciences and Hotspot Therapeutics.

Mr. Carmona holds an MBA from the Columbia Business School and received his BS in Civil Engineering from Universidad Tecnica Federico Santa Maria in Valparaiso, Chile.